Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13301
PUT
PepGen
PEPG
$200M
| $23.6K | ﹤0.01% |
13,100
-34,700
| -73% | -$56.4K |
|
13302
PUT
Invivyd
IVVD
$245M
| $23.6K | ﹤0.01% |
27,000
+13,700
| +103% | +$17.2K |
|
|
WPRT
13303
CALL
Westport Fuel Systems
WPRT
$37.4M
| $23.5K | ﹤0.01% |
+10,400
| New | +$20.9K |
|
13304
Fenbo Holdings
FEBO
$7.99M
| $23.3K | ﹤0.01% |
+26,163
| New | +$27.3K |
|
13305
TDH Holdings
PETZ
$14.1M
| $23.3K | ﹤0.01% |
18,511
+6,779
| +58% | +$7.92K |
|
13306
PUT
Solana Company
HSDT
$134M
| $23.1K | ﹤0.01% |
14,000
-5,300
| -27% | -$10.1K |
|
13307
Reborn Coffee
REBN
$6.45M
| $23.1K | ﹤0.01% |
+15,292
| New | +$32.2K |
|
13308
Innovative Eyewear
LUCY
$7.12M
| $23.1K | ﹤0.01% |
+29,596
| New | +$28.9K |
|
|
KBSX
13309
FST Corp
KBSX
$51.9M
| $23K | ﹤0.01% |
24,167
+12,482
| +107% | +$16K |
|
|
IPHA
13310
Innate Pharma
IPHA
$208M
| $22.9K | ﹤0.01% |
+12,441
| New | +$20.6K |
|
|
IBO
13311
Impact BioMedical
IBO
$57M
| $22.8K | ﹤0.01% |
+49,567
| New | +$29.3K |
|
|
AURE
13312
Aurelion Inc
AURE
$54.5M
| $22.5K | ﹤0.01% |
+10,678
| New | +$25.6K |
|
|
DDL
13313
CALL
Dingdong
DDL
$481M
| $22.4K | ﹤0.01% |
11,600
-2,200
| -16% | -$5.46K |
|
13314
PUT
CEMIG Preferred Shares
CIG
$6.01B
| $22.3K | ﹤0.01% |
10,600
-46,700
| -82% | -$109K |
|
|
SBTU
13315
T-REX 2X Long SBET Daily Target ETF
SBTU
$56.7M
| $22.2K | ﹤0.01% |
1,461
+284
| +24% | +$8.49K |
|
13316
Destination XL Group
DXLG
$35.3M
| $22.1K | ﹤0.01% |
+33,022
| New | +$21.7K |
|
|
PPBT
13317
Purple Biotech
PPBT
$2.8M
| $22.1K | ﹤0.01% |
+13,166
| New | +$44.4K |
|
13318
CALL
Genasys
GNSS
$67.9M
| $22.1K | ﹤0.01% |
13,000
-23,400
| -64% | -$44K |
|
13319
Neonode
NEON
$13.8M
| $22K | ﹤0.01% |
23,425
-17,524
| -43% | -$26K |
|
13320
Tempest Therapeutics
TPST
$12.5M
| $22K | ﹤0.01% |
+19,820
| New | +$32.7K |
|
|
SY
13321
PUT
So-Young International
SY
$274M
| $21.9K | ﹤0.01% |
14,800
-51,600
| -78% | -$124K |
|
13322
Barfresh Food Group
BRFH
$19.2M
| $21.8K | ﹤0.01% |
+10,903
| New | +$26.3K |
|
13323
PUT
Douglas Elliman
DOUG
$153M
| $21.8K | ﹤0.01% |
12,300
-96,400
| -89% | -$173K |
|
|
ORBS
13324
Eightco Holdings
ORBS
$369M
| $21.7K | ﹤0.01% |
31,130
+20,376
| +189% | +$18.3K |
|
13325
CALL
PDS Biotechnology
PDSB
$32.8M
| $21.6K | ﹤0.01% |
24,500
+13,200
| +117% | +$14K |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.